All Industries

Top Therapeutics Companies

765 Therapeutics companies, sorted by total funding raised.

765

Companies

$40.1B

Combined Funding

6

Funded (Last 60d)

Grant

Top Stage

Indexed tracks 765 Therapeutics companies that have collectively raised $40.1B in documented funding. The most-funded therapeutics companies tracked include Paratek Pharmaceuticals and Sana Biotechnology. 6 companies closed a new round in the last 60 days, with Grant being the most common funding stage.

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025
Candid TherapeuticsClosed

Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...

San Diego, United States11–50Biotech, Therapeutics
Venture RoundTotal funding$875.0MMar 2026
Mirum PharmaceuticalsIPO

Mirum Pharmaceuticals, Inc. is a clinical-stage therapeutics company developing a novel approach ...

Foster City, United States201–500Biotech, Healthcare
ConvertibleTotal funding$788.5MMay 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
Edgewise TherapeuticsIPO

Edgewise Therapeutics develops novel medicines for people living with serious cardiovascular dise...

Boulder, United States51–200Biotech, Healthcare
Growth EquityTotal funding$585.0MApr 2025
Phathom PharmaceuticalsIPO

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing ...

Florham Park, United States201–500Biotech, Healthcare
Venture RoundTotal funding$580.3MJan 2026
CelcuityIPO

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Minneapolis, United States51–200Biotech, Diagnostics
ConvertibleTotal funding$550.1MAug 2025
Beam TherapeuticsIPO

Biotechnology company developing precision genetic medicines through proprietary base editing tec...

Cambridge, United States201–500Biotech, Healthcare
Growth EquityTotal funding$528.0MFeb 2026
Relay TherapeuticsIPO

Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...

Cambridge, United States51–200Biotech, Drug Discovery
Series CTotal funding$520.0MDec 2018
Encoded Therapeutics

Gene therapy company developing precision gene therapies for debilitating neurological disorders,...

South San Francisco, United States51–200Biotech, Therapeutics
Series FTotal funding$514.0MSep 2026
Carmot TherapeuticsAcquired

Carmot Therapeutics was a clinical-stage biotech developing GLP-1-based therapeutics for obesity ...

Berkeley, United States11–50Biotech, Therapeutics
Series ETotal funding$497.0MMay 2023
RAPT TherapeuticsIPO

Clinical-stage biopharmaceutical developing immune-targeting therapeutics for inflammatory and im...

San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$497.0MOct 2025
GenentechIPO

Biotechnology company that discovers and develops medicines for serious, life-threatening disease...

San Francisco, United States10001+Biotech, Drug Discovery
Corporate RoundTotal funding$492.3MFeb 1990
nChroma Bio

Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...

Boston, United States51–200Biotech, Genomics
Venture RoundTotal funding$470.0MDec 2024
Crinetics Pharmaceuticals, Inc.Acquired

Crinetics develops and commercializes therapies for endocrine diseases and endocrine-related tumo...

San Diego, United States11–50Biotech, Healthcare
Venture RoundTotal funding$460.3MJan 2026
Nektar TherapeuticsIPO

Research-based development stage biopharmaceutical company that discovers and develops innovative...

San Francisco, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$460.0MFeb 2026
ImmunomedicsAcquired

Biotechnology company focused on the development of antibody-drug conjugates for the treatment of...

Morris Plains, United States201–500Biotech, Oncology
Private EquityTotal funding$459.0MMay 2020

Frequently Asked Questions

How many Therapeutics companies are tracked on Indexed?

Indexed tracks 765 Therapeutics companies, sorted by total funding raised.

How much funding have Therapeutics companies raised in total?

The Therapeutics companies tracked by Indexed have collectively raised $40.1B in documented funding.

What are the top-funded Therapeutics companies?

The most-funded Therapeutics companies tracked include Paratek Pharmaceuticals, Sana Biotechnology, Abogen Biosciences.

Who are the top investors in Therapeutics?

Leading investors active in Therapeutics include Polaris Partners, NFX, Amgen.

Explore More

Other Industries